ABL Bio Inc. (KOSDAQ:298380)
South Korea
· Delayed Price · Currency is KRW
190,600
-10,400 (-5.17%)
At close: Dec 5, 2025
ABL Bio Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 10,506,856 | 1,443,630 | 1,178,156 | 1,099,129 | 1,041,424 |
| Market Cap Growth | 484.69% | 22.53% | 7.19% | 5.54% | - |
| Enterprise Value | 10,423,081 | 1,335,337 | 1,126,398 | 1,038,936 | - |
| Last Close Price | 190600.00 | 29900.00 | 24600.00 | 23000.00 | 22100.00 |
| PE Ratio | - | - | - | 342.55 | - |
| PS Ratio | 118.81 | 43.22 | 17.97 | 16.33 | 195.31 |
| PB Ratio | 57.66 | 8.63 | 15.90 | 15.81 | 18.61 |
| P/TBV Ratio | 58.57 | 8.91 | 16.47 | 16.43 | 19.50 |
| P/FCF Ratio | - | - | - | 15.69 | - |
| P/OCF Ratio | - | - | - | 15.24 | - |
| EV/Sales Ratio | 117.86 | 39.98 | 17.18 | 15.44 | - |
| EV/EBITDA Ratio | - | - | - | 321.37 | - |
| EV/EBIT Ratio | - | - | - | 1144.20 | - |
| EV/FCF Ratio | -192.92 | - | - | 14.83 | - |
| Debt / Equity Ratio | 0.24 | 0.26 | 0.59 | 0.60 | 0.01 |
| Debt / EBITDA Ratio | - | - | - | 12.94 | - |
| Debt / FCF Ratio | - | - | - | 0.60 | - |
| Asset Turnover | 0.37 | 0.17 | 0.38 | 0.54 | - |
| Quick Ratio | 2.49 | 2.24 | 1.71 | 1.09 | 5.01 |
| Current Ratio | 2.53 | 2.28 | 1.81 | 1.12 | 5.20 |
| Return on Equity (ROE) | -15.80% | -46.01% | -3.69% | 5.12% | - |
| Return on Assets (ROA) | -7.78% | -18.93% | -0.95% | 0.45% | - |
| Return on Capital (ROIC) | -8.28% | -22.56% | -1.43% | 0.68% | - |
| Return on Capital Employed (ROCE) | -16.30% | -35.20% | -2.20% | 0.80% | -90.30% |
| Earnings Yield | -0.27% | -3.85% | -0.22% | 0.29% | -4.18% |
| FCF Yield | -0.51% | -5.43% | -2.90% | 6.38% | -4.02% |
| Buyback Yield / Dilution | -3.78% | -0.37% | -0.58% | -1.27% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.